Journal
/
/
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
DOI:

08:59 min

December 11, 2017

, , , , , ,

Chapters

  • 00:05Title
  • 01:39Generation of Targeted Therapy Resistant Subclones
  • 04:03Restoring Target-therapy Inhibitor Sensitivity by Candidate R-gene Knock-down
  • 06:31Results: Drug Resistant Subclone Generation and Sensitivity Restoration
  • 08:01Conclusion

Summary

Automatic Translation

This is a time- and cost-effective in vitro protocol investigating the mechanisms of acquired resistance to targeted therapeutic agents, which is a highly unmet medical need in cancer management.

Related Videos

Read Article